Early bird discount ends this week, early screening/prognostic testing + drug concomitant/biomarker precision development, the 5th P4 China returns with glory

On August 20-21, the Fifth P4 China 2021 International Precision Oncology Conference will be upgraded and launched in Beijing, with more than 50 academician authority/ National Food and Drug Administration/ China National Inspection Institute supervision/oncology clinical/leading diagnostic industry/precision pharmaceutical company experts etc.

Highlights of the structure of this forum:

Innovation and Application of Tumor Screening and Diagnosis Technology in A Conference

▪ Interpretation of the latest registration compliance policies and clinical recommendations

Oncology Innovative Drug Therapy and Companion Diagnosis Accurate Development and Transformation Application

▪ Explore the development of immune/targeted drugs under the guidance of biomarkers.

P4 China has confirmed the guests to watch first (the guest lineup is being continuously updated)

A meeting place

Fanjian Bing, founder and CEO of the medical reference

B meeting place

Shen Lin, Deputy Dean of Peking University Cancer Hospital

More heavy guests, look forward to the next breakdown!

P4 China 2021 is in hot investment promotion

The forums and exhibitions open keynote speeches, product demonstrations, cooperation invitations and other forms, all for you to show precision medical solutions!

Booths are limited and business opportunities are unlimited! First come first served, if you want to buy as soon as possible!

Early bird (1,000 yuan off) ends this week (2021.

In order to give back to colleagues in the pharmaceutical industry, P4 is specially open for limited-time group purchase benefits↓↓↓

Scan to enter the registration channel

Welcome to contact the organizing committee for more conference information!